- What a NMM Actually Is
- Who Certifies It and Who Writes the Exam
- The ABPMR Route: Who Qualifies
- How the Exam Blueprint Works: Two Intersecting Axes
- The Nine Disorder Categories in Plain Terms
- The Competency Axis: Where Clinical Reasoning Dominates
- What the Exam Day Looks Like
- Fees, Dates, and Calendar Mechanics
- Scoring and the Pass-Rate Question
- Sequencing Your Prep Around the Blueprint
- After Certification: Continuing Certification
- Frequently Asked Questions
- NMM here means Neuromuscular Medicine, a subspecialty certification issued through the American Board of Physical Medicine & Rehabilitation (ABPMR).
- The initial exam has 220 one-best-answer questions in four sections of 55, delivered at Pearson Professional Centers.
- Peripheral nerve and muscle disorders are joint largest on the disorder axis at 24-26% each.
- The 2026 on-time cost is $2,000 ($1,400 exam plus $600 processing); the exam runs October 19-23, 2026.
What a NMM Actually Is
If you searched "What is a NMM?" and landed here, the short answer is this: on this site, NMM stands for Neuromuscular Medicine, a physician subspecialty certification focused on diagnosing and managing diseases of the motor neuron, nerve root, plexus, peripheral nerve, neuromuscular junction, and muscle. Physicians who hold it have demonstrated, through a standardized examination, that they can handle the full spectrum of neuromuscular disease, from amyotrophic lateral sclerosis to myasthenia gravis to inherited myopathies.
The acronym is shared by several unrelated credentials in other fields, so it is worth being precise. Everything below concerns the subspecialty certification in Neuromuscular Medicine and nothing else. For other framings of the same question, see our explainers on what NMM is, what NMM stands for, and the meaning of NMM.
The credential is a subspecialty layered on top of a primary board certification. It is not an entry-level designation, and it is not something a medical student or general resident can sit for. It signals fellowship-level expertise in the electrodiagnostic, clinical, and therapeutic aspects of neuromuscular disease. If you want the certification-centered view, our page on NMM certification and the companion piece What Is NMM Certification? cover the same ground from different angles.
Who Certifies It and Who Writes the Exam
Two organizations are involved, and candidates frequently confuse their roles.
| Role | Organization | What It Does |
|---|---|---|
| Certifying issuer (ABPMR route) | American Board of Physical Medicine & Rehabilitation | Sets eligibility for its candidates, collects the application and fees, and issues the certificate |
| Exam developer and administrator | American Board of Psychiatry and Neurology (ABPN) | Develops, administers, and scores the shared initial subspecialty examination |
| Test delivery | Pearson Professional Centers | Hosts the in-person, proctored computer-based sitting |
The practical consequence: if you are applying through ABPMR, ABPMR's eligibility rules, fees, and deadlines govern your application, even though the questions come from the ABPN-developed exam. Do not mix in ABPN's own applicant-route details, which differ. Use the ABPMR subspecialty page as your source of truth for application mechanics.
The ABPMR Route: Who Qualifies
To apply through ABPMR, you need all of the following:
- Primary ABPMR certification in good standing. The subspecialty builds on, rather than replaces, your primary board status.
- An unrestricted medical license in the United States, its territories, or Canada.
- A 12-month ACGME-accredited post-residency neuromuscular medicine fellowship. At least six of those months must involve direct clinical care.
- Fellowship completion by August 31 before the examination.
- A recommendation from your program director.
The August 31 deadline is a hard planning constraint. Fellows finishing in June or July have little slack, so confirm your completion date early. A deeper breakdown of prerequisites lives in our guide to NMM requirements, and if you are still choosing a path into the field, our overview of NMM training explains what fellowship preparation looks like.
How the Exam Blueprint Works: Two Intersecting Axes
This is the single most misunderstood feature of the exam. The official content specifications (ABPN, December 1, 2025) list 17 weighted headings, but they are not 17 separate domains that add up to 100%. They form two intersecting dimensions:
- Dimension 1: Neuromuscular Disorders and Topics (nine headings)
- Dimension 2: Physician Competencies and Mechanisms (eight headings)
Every question is classified on both axes at once. A single question about electrodiagnostic findings in a demyelinating neuropathy counts toward the disorder axis (peripheral nerve disorders) and the competency axis (diagnostic procedures). That is why you should never add percentages across the two dimensions or try to normalize them into one study allocation. Our full walkthrough is in the NMM exam domains guide.
| Dimension 1: Disorder Axis | Weight |
|---|---|
| Motor neuron disorders | 15-18% |
| Spinal root disorders | 4-6% |
| Plexopathies | 4-6% |
| Peripheral nerve disorders | 24-26% |
| Neuromuscular junction transmission disorders | 16-20% |
| Muscle disorders | 24-26% |
| Hyper-excitability disorders | 1-3% |
| Autonomic dysfunction in neuromuscular diseases | 1-3% |
| Questions not associated with a specific neuromuscular disorder | 1-2% |
| Dimension 2: Competency Axis | Weight |
|---|---|
| Neuroscience and mechanism of disease | 7-13% |
| Clinical aspects of neurologic disease | 35-41% |
| Diagnostic procedures | 21-27% |
| Treatment/management | 17-23% |
| Interpersonal and communication skills | 1-3% |
| Professionalism | 1-3% |
| Practice-based learning and improvement | 1-3% |
| Systems-based practice | 1-3% |
The Nine Disorder Categories in Plain Terms
Peripheral nerve disorders and muscle disorders are the joint heavyweights at 24-26% each, which together account for roughly half the disorder axis. Neuromuscular junction disorders (16-20%) and motor neuron disorders (15-18%) fill most of the remainder. Here is what to master in each of the big four.
Peripheral Nerve Disorders (24-26%)
The broadest category, spanning acquired and inherited neuropathies and focal entrapments.
- Distinguishing axonal from demyelinating patterns on nerve conduction studies
- Acute and chronic inflammatory demyelinating polyneuropathies, including variants
- Hereditary neuropathies and how family history and electrodiagnostics point to subtype
- Metabolic, toxic, and nutritional neuropathies, and mononeuropathy localization
Muscle Disorders (24-26%)
Both inherited and acquired disease of skeletal muscle.
- Muscular dystrophies, congenital and metabolic myopathies
- Inflammatory myopathies and how biopsy, serology, and EMG findings separate them
- Channelopathies and toxic or drug-induced myopathy
- Interpreting creatine kinase, needle EMG, and biopsy patterns together
Neuromuscular Junction Transmission Disorders (16-20%)
A compact but heavily tested area with strong electrodiagnostic content.
- Myasthenia gravis: antibody profiles, repetitive nerve stimulation, single-fiber studies
- Lambert-Eaton myasthenic syndrome and its paraneoplastic associations
- Congenital myasthenic syndromes and botulism
- Treatment choices and crisis recognition
Motor Neuron Disorders (15-18%)
Degenerative and inherited disease of upper and lower motor neurons.
- ALS diagnostic criteria, mimics, and electrodiagnostic support
- Spinal muscular atrophy and other lower motor neuron syndromes
- Disease-modifying therapies, respiratory and nutritional management
The smaller categories, spinal root disorders and plexopathies (4-6% each), hyper-excitability disorders and autonomic dysfunction (1-3% each), and the unassigned category (1-2%), are low-weight but not ignorable. Plexopathy localization and radiculopathy electrodiagnosis, in particular, reappear inside questions that are also classified under diagnostic procedures.
The Competency Axis: Where Clinical Reasoning Dominates
The largest single heading across the whole blueprint is Clinical aspects of neurologic disease at 35-41%. That tells you the exam rewards bedside reasoning: recognizing presentations, building differentials, and choosing next steps, not just recalling electrodiagnostic cutoffs.
Behind it, diagnostic procedures (21-27%) covers nerve conduction studies, needle EMG, repetitive stimulation, biopsy, genetic and serologic testing, and when each is appropriate. Treatment/management (17-23%) covers pharmacologic and supportive therapy, immunotherapy decisions, and long-term care planning. Neuroscience and mechanism of disease (7-13%) addresses the underlying pathophysiology.
The four professionalism-style competencies, communication, professionalism, practice-based learning, and systems-based practice, are each only 1-3%. They are easy to dismiss, but they appear as scenario-based questions about disclosure, consent, quality improvement, and care coordination, and they are free points for candidates who read the stems carefully.
Key Takeaway
Because every question carries two classifications, a strong study plan covers disorders and competencies together: for each disease, learn the clinical picture, the diagnostic workup, and the management in one pass.
What the Exam Day Looks Like
The initial examination consists of 220 one-best-answer multiple-choice questions divided into four sections of 55. Per the administrator's format-and-scoring document (updated November 30, 2023), you get 230 minutes for questions and any optional breaks between sections, plus five minutes for the nondisclosure agreement and tutorial and five minutes for a survey, totaling a four-hour appointment.
Two details deserve attention:
- Breaks are optional, but they use your question timer. Time spent between sections comes out of the same 230 minutes.
- A source conflict exists. ABPMR's overview describes a single four-hour section with four hours of active testing plus tutorial, while the administrator document gives the detailed timer above. Confirm the exact structure in the instructions you receive when your sitting is scheduled.
Testing is closed book and in-person proctored. Personal electronics and study materials are prohibited. You must present two valid signed IDs, including one government-issued photo ID; name mismatches between your registration and your identification are a classic cause of avoidable trouble at check-in. Research or pretest items are included but excluded from scoring, and guessing is not penalized, so never leave an item blank.
For a candid look at how this format feels in practice, read how hard the NMM exam is.
Fees, Dates, and Calendar Mechanics
| Item | 2026 Detail |
|---|---|
| Examination fee | $1,400 |
| Processing fee | $600 |
| Total, on-time application | $2,000 |
| Late application surcharge | Additional $500 |
| Examination window | October 19-23, 2026 |
| Initial testing frequency | Every other year |
| Fellowship completion deadline | August 31 before the exam |
The every-other-year cadence matters enormously. Missing the application window or failing to finish fellowship by August 31 can mean a two-year wait, not a few months. Plan backward from October 2026 and treat the application deadline as non-negotiable. Full scheduling logistics are in our NMM exam dates guide, and the complete financial picture, including what recurs after certification, is in the NMM certification cost breakdown.
Scoring and the Pass-Rate Question
Passing means meeting an acceptable total-score performance standard. It is not a fixed pass-rate quota, so one candidate's success does not come at another's expense. No fixed numeric passing score is published in the materials this site relies on, so be wary of any source that quotes a specific cut score; our page on the NMM passing score explains what is and is not known.
On outcomes, the only issuer-specific datapoint available is ABPMR's October 2024 first-time initial-certification cohort: six candidates, six passes. That is 100%, but with a cohort that small it says almost nothing about your odds, and it is not an ABPN-wide or all-candidate rate. Treat it as a curiosity rather than a forecast. We unpack this in what the NMM pass rate data shows.
Sequencing Your Prep Around the Blueprint
Rather than a generic schedule, tie your calendar to the weights. Because the two heavyweight disorder categories are peripheral nerve and muscle, and because clinical aspects dominate the competency axis, an efficient sequence front-loads high-yield material and revisits it.
Peripheral Nerve Disorders
- Neuropathy patterns, nerve conduction interpretation, entrapment localization
- Fold in plexopathy and spinal root disorders, which share electrodiagnostic logic
Muscle Disorders
- Dystrophies, myopathies, channelopathies, inflammatory disease
- Pair every disorder with its EMG, CK, and biopsy signature
Junction and Motor Neuron Disease
- Myasthenic syndromes, ALS, spinal muscular atrophy
- Treatment and crisis management for each
Low-Weight Topics and Integration
- Hyper-excitability, autonomic dysfunction, the professionalism competencies
- Mixed practice questions testing clinical reasoning across disorders
Adjust the pacing to your fellowship experience, but keep the principle: weight your hours toward the categories the blueprint weights. For a fuller framework, see our NMM study guide and the NMM cheat sheet for last-week review. When you are ready to test yourself under realistic conditions, try the NMM practice test, which mirrors the one-best-answer format.
After Certification: Continuing Certification
Earning the credential is not the finish line. Continuing certification (CC) requires professionalism and licensure, lifelong learning, quality improvement, and a separate subspecialty assessment. The non-assessment requirements have reciprocity with your primary ABPMR certification, so you are not duplicating everything.
| CC Component | Requirement |
|---|---|
| Annual program fee | $360 |
| Category 1 CME | Average of 30 per year; 150 per five-year cycle |
| Self-assessment CME | 48 SA-CME credits per five-year cycle, reduced from 50 effective August 18, 2026 |
| Quality improvement | One IHHC project per five-year cycle |
| Subspecialty assessment | Separate 150-question CC examination, or the new article-based pathway |
On August 12, 2026, ABPMR announced an Article-Based Continuing Certification (ABCC) pathway for NMM beginning in 2027. It is a future maintenance option, and neither it nor the separate 150-question CC examination replaces the initial certification exam you take in 2026. If you are weighing the long-term picture, our analyses of whether the certification is worth it, the NMM salary guide, and NMM jobs look at where the credential is used and how it factors into careers in academic centers, neuromuscular clinics, and electrodiagnostic practices.
Frequently Asked Questions
NMM means Neuromuscular Medicine, a subspecialty physician certification. It is unrelated to other credentials that happen to share the same three letters. For more variations of this question, see what does NMM mean and what is a NMM.
You need primary ABPMR certification in good standing, an unrestricted US, territorial, or Canadian medical license, and completion of a 12-month ACGME-accredited neuromuscular medicine fellowship (with at least six months of direct clinical care) by August 31 before the exam, plus your program director's recommendation.
There are 220 one-best-answer questions in four sections of 55. The administrator document gives 230 minutes for questions and optional breaks, within a four-hour appointment. ABPMR's overview describes the structure slightly differently, so confirm your sitting's instructions.
On-time applications total $2,000: a $1,400 examination fee plus a $600 processing fee. Late applications add $500. The exam window is October 19-23, 2026, and initial testing is offered every other year.
On the disorder axis, peripheral nerve disorders and muscle disorders are each 24-26%. On the competency axis, clinical aspects of neurologic disease leads at 35-41%. Every question is classified on both axes, so these percentages are not additive.